Peter Soparkar, CHIEF OPERATING OFFICER at Adverum Biotechnologies, Inc. (ADVM), bought 50,000 shares at $4.22 ($211K) on 2025-12-05, disclosed to the SEC on 2025-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADVM | SELL | 2022-09-21 | $14K | — | Filing → |
| ADVM | BUY | 2022-04-20 | $25K | — | Filing → |
| ADVM | BUY | 2021-12-10 | $48K | — | Filing → |